CB2 activation by, for instance, β-caryophyllene, was reported to reduce TNF-α and IL-6 levels, which are thought to be a pivotal part of diabetic nephropathy and insulin resistance [8,46]. The gene discussed is CNR2; the disease is diabetic kidney disease.